Engineered nuclease may renew CRISPR interest, Caszyme says
An engineered CRISPR-Cas12l nuclease could spark renewed interest in the CRISPR approach, Caszyme says. The gene editing company published research in The CRISPR Journal detailing the performance characteristics of Asp2Cas12l M82, denoted as M82. The publication suggests M82 could be a compelling new tool for… Read More